What AI Monitoring Reveals About Consumer Drug Confusion
When a patient types ‘Can I take Ozempic and metformin together?’ into ChatGPT, three things happen at once: ChatGPT generates […]
AI Drug Monitoring: The Pharma Playbook for LLM Brand Intelligence
Every day, millions of patients and physicians type drug questions into ChatGPT, Gemini, Perplexity, and Claude. They ask whether Ozempic
When AI Mixes Clinical Data With Patient Stories: What Drug Companies Must Monitor Now
Ask ChatGPT about Ozempic’s side effects. You’ll get a confident paragraph that blends data from the SELECT cardiovascular outcomes trial
How Pharma Companies Monitor AI-Generated Drug Mentions Before the FDA Does
When a patient types ‘Is Ozempic safe for people with pancreatitis?’ into ChatGPT, the answer they receive is not written
The Dose Is Always the Argument: Why “how much?” is the most expensive question in medicine
There’s a quiet moment in almost every medication conversation where the science stops sounding like science and starts sounding like
Top “can I stop taking…” questions hiding in plain sight (and what people are really asking)
There’s a particular moment in modern pharmacology that doesn’t show up in clinical trials or prescribing inserts. It happens at
The Next SEO War in Pharma Happens Inside AI Answers
When a patient asks ChatGPT whether Ozempic or Mounjaro is better for weight loss, they get an answer. Not a
Most “drug interactions” aren’t exotic at all. They’re dinner. Or breakfast. Or the innocent-looking supplement aisle.
And while clinicians think in terms of CYP enzymes and receptor binding, patients often think in simpler terms: Can I
AI Monitoring in Pharmacovigilance: What Drug Safety Teams Are Missing
Drug safety surveillance has a new blind spot. Millions of patients are now asking ChatGPT, Gemini, Claude, and Perplexity about
What LLMs Get Wrong About Prescribing Information (And How Pharma Can Track It)
Prescribing information is the most legally precise document in medicine. Every word in a package insert has survived FDA review,
Monitor AI Before Your Drug Launch Kills Your Brand
When Pfizer launched Paxlovid in late 2021, the company had a distribution problem, a supply chain problem, and a rebound
Pregnancy, Pills & the Questions Nobody Really Wants to Guess On
Pregnancy is one of those states where pharmacology becomes less about mechanism diagrams and more about uncertainty management. The questions
